Cuzin Béatrice, Giuliano François, Jamin Christian, Legros Jean-Jacques, Lejeune Hervé, Rigot Jean-Marc, Roger Marc
Service d'Urologie, Hôpital Edouard Herriot, Lyon, France.
Prog Urol. 2004 Feb;14(1):1-14.
There is growing interest in the hormonal changes of the ageing male, particularly in view of the expected growth of the population of males over the age of 50. Current research topics essentially concern androgen decline in the aging male (ADAM), or partial androgen deficiency of the aging male (PADAM), commonly called "andropause" in France. Although progress has been made in our knowledge concerning androgen deficiency of the aging male, it is still incomplete, sometimes confused, and some aspects of androgen replacement therapy remain controversial. The International Society for the Study of the Aging Male (ISSAM) therefore considered it appropriate to propose a series of practical and official guidelines concerning the investigation, treatment and surveillance of late-onset hypogonadism in males. The French translation of these recent international guidelines is presented and discussed in this article.
人们对老年男性的激素变化越来越感兴趣，特别是考虑到50岁以上男性人口预计会增长。当前的研究主题主要涉及老年男性雄激素缺乏（ADAM），或老年男性部分雄激素缺乏（PADAM），在法国通常称为“男性更年期”。尽管我们在老年男性雄激素缺乏方面的知识取得了进展，但仍然不完整，有时还很混乱，雄激素替代疗法的某些方面仍存在争议。因此，国际老年男性研究学会（ISSAM）认为有必要就男性迟发性性腺功能减退的调查、治疗和监测提出一系列实用的官方指南。本文介绍并讨论了这些最新国际指南的法语译文。
